147 related articles for article (PubMed ID: 16142334)
1. Distinct expression of Survivin splice variants in breast carcinomas.
Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
[TBL] [Abstract][Full Text] [Related]
2. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
[TBL] [Abstract][Full Text] [Related]
3. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression.
Krieg A; Mahotka C; Krieg T; Grabsch H; Müller W; Takeno S; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD
Br J Cancer; 2002 Mar; 86(5):737-43. PubMed ID: 11875736
[TBL] [Abstract][Full Text] [Related]
4. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.
Mahotka C; Wenzel M; Springer E; Gabbert HE; Gerharz CD
Cancer Res; 1999 Dec; 59(24):6097-102. PubMed ID: 10626797
[TBL] [Abstract][Full Text] [Related]
5. An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy.
Zhu N; Gu L; Findley HW; Li F; Zhou M
Oncogene; 2004 Sep; 23(45):7545-51. PubMed ID: 15334064
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
Meng H; Lu C; Mabuchi H; Tanigawa N
Cancer Lett; 2004 Dec; 216(2):147-55. PubMed ID: 15533590
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
[TBL] [Abstract][Full Text] [Related]
8. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
[TBL] [Abstract][Full Text] [Related]
9. Survivin expression is regulated by an epigenetic mechanism for DMBA-induced hamster buccal-pouch squamous-cell carcinomas.
Chen YK; Hsue SS; Lin LM
Arch Oral Biol; 2005 Jun; 50(6):593-8. PubMed ID: 15848153
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients.
Taubert H; Kappler M; Bache M; Bartel F; Köhler T; Lautenschläger C; Blümke K; Würl P; Schmidt H; Meye A; Hauptmann S
Oncogene; 2005 Aug; 24(33):5258-61. PubMed ID: 15856009
[TBL] [Abstract][Full Text] [Related]
11. In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma.
Takashima H; Nakajima T; Moriguchi M; Sekoguchi S; Nishikawa T; Watanabe T; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
Liver Int; 2005 Feb; 25(1):77-84. PubMed ID: 15698402
[TBL] [Abstract][Full Text] [Related]
12. Expression of oestrogen receptor alpha variants in non-malignant breast and early invasive breast carcinomas.
Chappell SA; Johnson SM; Shaw JA; Walker RA
J Pathol; 2000 Oct; 192(2):159-65. PubMed ID: 11004691
[TBL] [Abstract][Full Text] [Related]
13. Differential subcellular localization of functionally divergent survivin splice variants.
Mahotka C; Liebmann J; Wenzel M; Suschek CV; Schmitt M; Gabbert HE; Gerharz CD
Cell Death Differ; 2002 Dec; 9(12):1334-42. PubMed ID: 12478470
[TBL] [Abstract][Full Text] [Related]
14. Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis.
Kishi H; Igawa M; Kikuno N; Yoshino T; Urakami S; Shiina H
J Urol; 2004 May; 171(5):1855-60. PubMed ID: 15076293
[TBL] [Abstract][Full Text] [Related]
15. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas.
Tanaka K; Iwamoto S; Gon G; Nohara T; Iwamoto M; Tanigawa N
Clin Cancer Res; 2000 Jan; 6(1):127-34. PubMed ID: 10656440
[TBL] [Abstract][Full Text] [Related]
16. Ectopic expression of interferon regulatory factor-1 promotes human breast cancer cell death and results in reduced expression of survivin.
Pizzoferrato E; Liu Y; Gambotto A; Armstrong MJ; Stang MT; Gooding WE; Alber SM; Shand SH; Watkins SC; Storkus WJ; Yim JH
Cancer Res; 2004 Nov; 64(22):8381-8. PubMed ID: 15548708
[TBL] [Abstract][Full Text] [Related]
17. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of HOX genes in human invasive breast carcinoma.
Makiyama K; Hamada J; Takada M; Murakawa K; Takahashi Y; Tada M; Tamoto E; Shindo G; Matsunaga A; Teramoto K; Komuro K; Kondo S; Katoh H; Koike T; Moriuchi T
Oncol Rep; 2005 Apr; 13(4):673-9. PubMed ID: 15756441
[TBL] [Abstract][Full Text] [Related]
19. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas.
Lu CD; Altieri DC; Tanigawa N
Cancer Res; 1998 May; 58(9):1808-12. PubMed ID: 9581817
[TBL] [Abstract][Full Text] [Related]
20. Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies.
Caldas H; Honsey LE; Altura RA
Mol Cancer; 2005 Mar; 4(1):11. PubMed ID: 15743529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]